Ryan C Eid1, Marina L Palumbo2, Katherine N Cahill3. 1. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass; Harvard Medical School, Boston, Mass. 2. Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, Mass. 3. Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, Tenn. Electronic address: Katherine.cahill@vumc.org.
Abstract
BACKGROUND: Aspirin-exacerbated respiratory disease (AERD) is a condition of the upper and lower respiratory tract characterized by reactions to nonsteroidal anti-inflammatory drugs. The Severe Asthma Research Program reported a strong association between perimenstrual asthma (PMA) and aspirin-sensitive asthma. OBJECTIVE: To evaluate the prevalence and characteristics of PMA among a cohort of patients with AERD. METHODS: Women 18 years and older enrolled in the Brigham and Women's AERD registry were surveyed about their reproductive, asthma, and sinus history. Subjects reporting the development of asthma before menopause were included. Continuous and categorical variables were compared between those reporting menstruation as a trigger for asthma symptoms and those who did not. Covariates expected a priori to have a positive effect on the odds of PMA were included in a multivariate logistic regression model to test associations between PMA and clinical factors. RESULTS: Among females of childbearing potential, 369 of 695 responded to the survey and 322 met inclusion criteria. Twenty-four percent of subjects (n = 74) reported PMA. Earlier age of AERD onset, concurrent worsening of sinus symptoms the week before or during menstruation, increased emergency department visits for asthma, and a change in the severity of respiratory symptoms at menopause were more common in PMA. Earlier age at first nonsteroidal anti-inflammatory drug-induced respiratory reaction and emergency department visits increased the odds of reporting PMA. CONCLUSIONS: PMA and increased sinus symptoms with menstruation are common in females with AERD. Females with AERD should be counseled about upper and lower respiratory symptom deterioration with menstruation.
BACKGROUND:Aspirin-exacerbated respiratory disease (AERD) is a condition of the upper and lower respiratory tract characterized by reactions to nonsteroidal anti-inflammatory drugs. The Severe Asthma Research Program reported a strong association between perimenstrual asthma (PMA) and aspirin-sensitive asthma. OBJECTIVE: To evaluate the prevalence and characteristics of PMA among a cohort of patients with AERD. METHODS:Women 18 years and older enrolled in the Brigham and Women's AERD registry were surveyed about their reproductive, asthma, and sinus history. Subjects reporting the development of asthma before menopause were included. Continuous and categorical variables were compared between those reporting menstruation as a trigger for asthma symptoms and those who did not. Covariates expected a priori to have a positive effect on the odds of PMA were included in a multivariate logistic regression model to test associations between PMA and clinical factors. RESULTS: Among females of childbearing potential, 369 of 695 responded to the survey and 322 met inclusion criteria. Twenty-four percent of subjects (n = 74) reported PMA. Earlier age of AERD onset, concurrent worsening of sinus symptoms the week before or during menstruation, increased emergency department visits for asthma, and a change in the severity of respiratory symptoms at menopause were more common in PMA. Earlier age at first nonsteroidal anti-inflammatory drug-induced respiratory reaction and emergency department visits increased the odds of reporting PMA. CONCLUSIONS:PMA and increased sinus symptoms with menstruation are common in females with AERD. Females with AERD should be counseled about upper and lower respiratory symptom deterioration with menstruation.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Kai Triebner; Ane Johannessen; Luca Puggini; Bryndís Benediktsdóttir; Randi J Bertelsen; Ersilia Bifulco; Shyamali C Dharmage; Julia Dratva; Karl A Franklin; Thórarinn Gíslason; Mathias Holm; Deborah Jarvis; Bénédicte Leynaert; Eva Lindberg; Andrei Malinovschi; Ferenc Macsali; Dan Norbäck; Ernst R Omenaas; Francisco J Rodríguez; Eirunn Saure; Vivi Schlünssen; Torben Sigsgaard; Trude D Skorge; Gunilla Wieslander; Elisabeth Zemp; Cecilie Svanes; Steinar Hustad; Francisco Gómez Real Journal: J Allergy Clin Immunol Date: 2015-10-02 Impact factor: 10.793
Authors: José L Sánchez-Ramos; Antonio R Pereira-Vega; Francisco Alvarado-Gómez; Jose A Maldonado-Pérez; Cecilie Svanes; Francisco Gómez-Real Journal: Expert Rev Respir Med Date: 2017-01 Impact factor: 3.772
Authors: Chitra K Rao; Charity G Moore; Eugene Bleecker; William W Busse; William Calhoun; Mario Castro; Kian Fan Chung; Serpil C Erzurum; Elliot Israel; Douglas Curran-Everett; Sally E Wenzel Journal: Chest Date: 2013-04 Impact factor: 9.410